33
Views
85
CrossRef citations to date
0
Altmetric
Original Article

Radiotoxicity of Intracellular 67Ga, 125I and 3H

Nuclear Versus Cytoplasmic Radiation Effects in Murine L1210 Leukaemia

, &
Pages 225-241 | Received 19 Jun 1975, Accepted 21 Jul 1975, Published online: 03 Jul 2009
 

Summary

L1210 leukaemia cells were labelled with various doses of 67Ga-citrate, 3H-thymidine, or 125I-iododeoxyuridine to evaluate the cytocidal effects of the intracellular decay of the three radionuclides. Based on radioisotope incorporation data, cellular dimensions, and intracellular radioisotope distributions (3H and 125I intranuclear, 67Ga cytoplasmic) the rates of deposition of cellular, nuclear, and cytoplasmic energy were calculated.

In terms of energy absorption/cell, 67Ga (LD50: 2250 keV/hr; 69 rad/hr) was much less toxic than either 3H (LD50: 325 keV/hr; 10 rad/hr) or 125I (LD50: 50 keV/hr; 1·5 rad/hr). In terms of energy absorption/nucleus, 67Ga and 3H produced almost identical effects (LD50: 230 versus 255 keV/hr; 22·2 versus 24·6 rad/hr), but 125I remained much more toxic (LD50: 40 keV/hr; 3·9 rad/hr).

These findings indicate that, although decay by electron capture in the cell nucleus (125I) is highly destructive, the same type of decay occurring in the cytoplasm (67Ga) is ineffective in killing L1210 cells. An analysis of the data suggests that the cytotoxic effects of the three radioisotopes result exclusively from nuclear damage. Cytoplasmic absorption of radiation energy appears to contribute little, if anything, to the lethal effects of ionizing radiations.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.